Koers Northwest Biotherapeutics, Inc OTC Bulletin Board
Aandelen
US66737P5017
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | 1,68 mln. 1,55 mln. | Omzet 2023 | 1,93 mln. 1,77 mln. | Marktkapitalisatie | 822 mln. 755 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -105 mln. -96,45 mln. | Nettowinst (verlies) 2023 | -62 mln. -56,95 mln. | EV/omzet 2022 | 505 x |
Nettoschuld 2022 | 19,29 mln. 17,72 mln. | Nettoschuld 2023 | 43,43 mln. 39,9 mln. | EV/omzet 2023 | 448 x |
K/w-verhouding 2022 |
-7,59
x | K/w-verhouding 2023 |
-11,7
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 90,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 17-05-07 |
Alton Boynton
FOU | Founder | 79 | 18-03-96 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-01-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 18-03-96 |
Linda Powers
CEO | Chief Executive Officer | 68 | 17-05-07 |
Navid Malik
BRD | Director/Board Member | 55 | 01-04-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,49% | 118 mld. | |
+13,73% | 106 mld. | |
-2,15% | 24,28 mld. | |
+1,14% | 21,96 mld. | |
-9,35% | 18,16 mld. | |
-42,28% | 16,37 mld. | |
-16,64% | 15,56 mld. | |
+6,38% | 13,63 mld. | |
+29,48% | 12,27 mld. |
- Beurs
- Aandelen
- Koers NWBO
- Koers